Alcami Opens New Advanced Pharma Storage and Services Facility in Central North Carolina

Alcami Corporation announced the opening of its new 65,000 ft² state-of-the-art Pharma Storage and Services operations facility in Garner, North Carolina close to the Research Triangle Park biotech and pharma hub.

The new central North Carolina facility, now accepting client pallets for ambient/controlled room temperature storage, adds to the company's network of GMP storage facilities across North America. Part of the company's intentional strategy to strengthen its pharma storage and services business with key locations to streamline operations for biotech and pharma clients, the site will phase in stability storage and aliquoting, followed by cold storage later this year.

With the opening of this new facility and the recent acquisition of Pacific Pharmaceutical Services, a West Coast provider of cGMP pharma storage and services, Alcami now offers an extensive high-quality, secure GMP storage network across multiple US locations in the Northeast, Southeast, and West Coast covering a wide range of GMP temperature storage conditions, from ≤-135˚C to 70˚C, including all ICH stability conditions for vaccines, biopharma therapies, cell banks, tissues, pharmaceutical compounds, raw materials, components, and medical devices.

The pipeline of complex medicines requiring specific warehouse conditions and support is only increasing, and Alcami's new location adjacent to the Research Triangle Park will help alleviate the constraints and bottlenecks impacting the pharma supply chain. As the region's specialized site offering these storage specifications in conjunction with seamless access to a broad set of laboratory and manufacturing services, Alcami can provide custom-designed solutions for each unique client product.


Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox!

Sign up now!

  • <<
  • >>

Join the Discussion